Cargando…
Relationship between metabolic reprogramming and drug resistance in breast cancer
Breast cancer is the leading cause of cancer death in women. At present, chemotherapy is the main method to treat breast cancer in addition to surgery and radiotherapy, but the process of chemotherapy is often accompanied by the development of drug resistance, which leads to a reduction in drug effi...
Autores principales: | Lv, Linlin, Yang, Shilei, Zhu, Yanna, Zhai, Xiaohan, Li, Shuai, Tao, Xufeng, Dong, Deshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434120/ https://www.ncbi.nlm.nih.gov/pubmed/36059650 http://dx.doi.org/10.3389/fonc.2022.942064 |
Ejemplares similares
-
Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters
por: Lin, Kexin, et al.
Publicado: (2023) -
Success stories of natural product-derived compounds from plants as multidrug resistance modulators in microorganisms
por: Zhai, Xiaohan, et al.
Publicado: (2023) -
Machine Learning Techniques Applied to the Study of Drug Transporters
por: Kong, Xiaorui, et al.
Publicado: (2023) -
Research Progress on the Positive and Negative Regulatory Effects of Rhein on the Kidney: A Review of Its Molecular Targets
por: Zhu, Yanna, et al.
Publicado: (2022) -
Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
por: Li, Shuai, et al.
Publicado: (2021)